Hasil Pencarian - Sara Galimberti

Perbaiki Hasil
  1. 1
    Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases

    Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases oleh Daniele Focosi, Sara Galimberti, Mario Petrini

    Diterbitkan 2007-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Precision Medicine in Lymphoma by Innovative Instrumental Platforms

    Precision Medicine in Lymphoma by Innovative Instrumental Platforms oleh Antonello Di Paolo, Antonello Di Paolo, Elena Arrigoni, Giacomo Luci, Federico Cucchiara, Romano Danesi, Romano Danesi, Sara Galimberti, Sara Galimberti

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Editorial: Measurable residual disease in hematologic malignancies

    Editorial: Measurable residual disease in hematologic malignancies oleh Francesco Buccisano, Raffaele Palmieri, Monica L. Guzman, Sara Galimberti

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia

    BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia oleh Federica Loscocco, Giuseppe Visani, Sara Galimberti, Antonio Curti, Alessandro Isidori

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool

    Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool oleh Sara Galimberti, Serena Balducci, Francesca Guerrini, Marzia Del Re, Rossella Cacciola

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches

    Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches oleh Barbara Izzo, Enrico Marco Gottardi, Santa Errichiello, Filomena Daraio, Claudia Baratè, Sara Galimberti

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey

    Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey oleh Maria Teresa Voso, Felicetto Ferrara, Sara Galimberti, Alessandro Rambaldi, Alessandro Rambaldi, Adriano Venditti

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia

    Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia oleh Marialuisa Polillo, Sara Galimberti, Claudia Baratè, Mario Petrini, Romano Danesi, Antonello Di Paolo

    Diterbitkan 2015-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    PRDI-BF1 and PRDI-BF1β isoform expressions correlate with disease status in multiple myeloma patients

    PRDI-BF1 and PRDI-BF1β isoform expressions correlate with disease status in multiple myeloma patients oleh Gabriele Buda, Francesca Guerrini, Sara Galimberti, Enrico Orciuolo, Simone Pacini, Elisa Mazzantini, Mario Petrini

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia

    Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia oleh Francesca Martini, Nadia Cecconi, Aldo Paolicchi, Sara Galimberti, Giulia Cervetti, Gabriele Buda, Mario Petrini

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Different types of amyloid concomitantly present in the same patients

    Different types of amyloid concomitantly present in the same patients oleh Francesca Martini, Gabriele Buda, Vincenzo De Tata, Sara Galimberti, Enrico Orciuolo, Matilde Masini, Mario Petrini

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

    Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study oleh Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canesastraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini

    Diterbitkan 2015-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

    Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study oleh Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canestraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini

    Diterbitkan 2015-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Prethymic Cytoplasmic CD3 Negative Acute Lymphoblastic Leukemia or Acute Undifferentiated Leukemia: A Case Report

    Prethymic Cytoplasmic CD3 Negative Acute Lymphoblastic Leukemia or Acute Undifferentiated Leukemia: A Case Report oleh Elisa Cannizzo, Giovanni Carulli, Luigi Del Vecchio, Antonio Azzarà, Sara Galimberti, Virginia Ottaviano, Frederic Preffer, Mario Petrini

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results

    Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results oleh Rita Fazzi, Iacopo Petrini, Nicola Giuliani, Riccardo Morganti, Giovanni Carulli, Benedetta Dalla Palma, Laura Notarfranchi, Sara Galimberti, Gabriele Buda

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy

    Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy oleh Raffaele Palmieri, Atto Billio, Felicetto Ferrara, Sara Galimberti, Roberto M. Lemoli, Roberto M. Lemoli, Elisabetta Todisco, Federico Moretti, Adriano Venditti

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region

    Real-life Diagnostic and Therapeutic Approach to CLL: A New Proposal from an Expert Panel in Tuscany Region oleh Monica Bocchia, Alberto Bosi, Enrico Capochiani, Stefania Ciolli, Romano Danesi, Sara Galimberti, Alessandro Gozzetti, Sabrina Moretti, Ubaldo Occhini, Mario Petrini

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

    Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial... oleh Stefano Luminari, Sara Galimberti, Annibale Versari, Irene Biasoli, Antonella Anastasia, Chiara Rusconi, Angela Ferrari, Mario Petrini, Martina Manni, Massimo Federico

    Diterbitkan 2016-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2

    Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2 oleh Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, Giovanni Li Volti, Giuseppe Alberto Palumbo, Arcangelo Liso

    Diterbitkan 2020-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

    Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease oleh Rita Tavarozzi, Enrica Manzato, Riccardo Morganti, Paola Sammuri, Giulia Tarrini, Federica Ricci, Giordana Mattana, Sara Galimberti, Mario Petrini, Giovanni Carulli

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: